Clinical Trial

Implementation of the Pain and Irritability of Unknown Origin (PIUO) Pathway in Community Pediatric Practices

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 11, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
The Pain and Irritability of Unknown Origin (PIUO) Pathway is a clinical pathway that was developed to evaluate and manage unexplained pain and irritability for children with severe neurological impairments (SNI) who cannot verbally communicate 'where it hurts'. The investigators studied the usefulness of the Pathway with families and expert clinicians in 4 centres across Canada. The aim of this Phase 2 study is to determine whether this tool can transfer from hospital research centres into the community. The Pathway will be used by community pediatricians across British Columbia (BC) when they see patients with PIUO. The investigators want to know how well these pediatricians can follow the Pathway. The goal is to create a systematic, cohesive approach to enhance the clinical care for all children with complex medical needs experiencing PIUO.
Trial Details
NCT Number NCT06869928
Lead Sponsor University of British Columbia
Conditions Pain, Irritability, Neuropathic Pain
Enrollment 20 participants
Start Date 2024-06-28
Primary Completion 2026-03 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2025-03-11